Collegium Pharmaceutical Stock (NASDAQ: COLL)

Collegium Pharmaceutical

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Medicine,Development,Laboratory:,Caucasian,Female,Scientist,Using,Microscope,,Analyzes,Petri

Analyst Color

Equities

News

Upgrades

Price Target

Markets

Analyst Ratings

Movers

Trading Ideas

General

COLL

Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, and undervaluation.

Collegium&#39;s Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham

Titoli a dividendo scelti dai migliori analisti di Wall Street

Pre-Market Outlook

CHPT

DLTR

EVTC

SPGI

STNE

S&amp;P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday

Guidance

Buybacks

Small Cap

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial 

Why Collegium Pharmaceutical Shares Are Gaining Today

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical Inc

COLLEXIS HOLDINGS INC by Collexis Holdings, Inc.

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

Collaborative Investment Series Trust Anydrus Advantage ETF

Collaborative Investment Series Trust Goose Hollow Hedged Equity ETF

Collaborative Investment Series Trust Goose Hollow Multi-Strategy Income ETF

Collaborative Investment Series Trust MOHR IND NAV ETF

Collaborative Investment Series Trust Mohr Company Nav ETF

Collaborative Investment Series Trust Mohr Growth ETF

Collaborative Investment Series Trust Mohr Sector Nav ETF

Collaborative Investment Series Trust Rareview 2x Bull Cryptocurrency & Precious Metals ETF

Collaborative Investment Series Trust Rareview Inflation / Deflation ETF

Collaborative Investment Series Trust Rareview Systematic Equity ETF

Collaborative Investment Series Trust Rareview Total Return Bond ETF

COLLECTIVE AUDIENCE INC by Collective Audience, Inc.

Collective Audience Inc

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

Collective Mining Ltd

Collective Mining Ltd Ordinary Shares

Colliers International Group Inc. - Subordinate Voting Shares

Colliers International Group Inc

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

Management

Press Releases

Collegium Appoints Vikram Karnani as Chief Executive Officer

Earnings

Collegium Reports Record Third Quarter 2024 Financial Results

Health Care

Collegium to Participate in Upcoming Investor Conferences

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Collegium Provides 2025 Financial Guidance and Business Update

Collegium Appoints Nancy S. Lurker to its Board of Directors

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

TSX:GUD

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

ANI Pharmaceuticals

Arvinas

BGM Group

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harrow

Indivior

Innoviva

Liquidia

Maze Therapeutics

Nuvation Bio

Ocular Therapeutix

Omeros

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Tilray Brands

Xeris Biopharma Holdings, Inc. - Common Stock

Comments

Collegium Pharmaceutical

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga